Growing the love for investing
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
As of 7-9-12, I believe it's still a great time to get on board.
Since I can't seem to be able to post a comment, I'll reply to this one. I followed Arena Pharma for 3 years and struck gold when it got approval. I see the same situation brewing with Galena. All the news is the same, the same "pump and dump" comments, the same "small pharma" company, etc. I bought in at $1.51 just like I did with Arena, cause this company has a drug that works. Arena jumped to $11 or $12 and Gale will do the same, the day it gets approved.
It's like dejva vu all over again...